Medivir’s Nomination Committee proposes new Board of Directors ahead of 2017 AGM
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced the Nomination Committee’s proposal for a new Board of Directors that will be submitted to the 2017 Annual General Meeting. The 2016-2017 Nomination Committee comprises representatives of the company’s three largest shareholders at the end of the third quarter of 2016 who have accepted a seat on the Nomination Committee, and the Chairman of the Board. The composition of the 2016-2017 Nomination Committee was as follows: · Anders Hallberg, Chairman of the Nomination Committee, representing HealthInvest Partners AB